MSN Exam for Diabetes Insipidus

EXPLANATION

 

✔Correct answer:

"I plan to gradually stop taking the vasopressin on my own." This statement indicates a significant misunderstanding about the management of diabetes insipidus (DI) and the role of vasopressin (or its synthetic analogue, desmopressin) in its treatment. Vasopressin is crucial for controlling the symptoms of DI, such as excessive urination and thirst, by compensating for the body's lack of natural antidiuretic hormone (ADH) or its inability to respond to ADH. Stopping vasopressin without medical supervision can lead to a return of symptoms, potential dehydration, and electrolyte imbalances. It is essential for patients to understand that any changes to their medication regimen should only be made under the guidance of a healthcare professional.

Imagine your body as a garden that requires regular watering to stay healthy. Vasopressin acts like an automatic watering system, ensuring the garden gets just the right amount of water it needs. Deciding to turn off this system on your own, without consulting a gardening expert (in this case, your doctor), could lead to your garden getting too much or too little water, harming its health. Similarly, stopping vasopressin on your own could disrupt your body's fluid balance, leading to health issues.

 

✘Incorrect answer options:

"I'll make sure to drink an amount of fluids that matches my urine output." This statement suggests a correct understanding of fluid management in DI. Patients are advised to balance fluid intake with output to prevent dehydration and maintain electrolyte balance, as excessive urination is a hallmark of DI.

"I'll wear my medical alert bracelet at all times." Wearing a medical alert bracelet is an important safety measure for patients with DI. It ensures that in case of an emergency, responders will be aware of the patient's condition and the need for specific care, particularly regarding fluid and electrolyte management.

"I'll weigh myself daily, using the same scale each time." This is a good practice for patients with DI as it helps in monitoring for sudden changes in weight, which can indicate issues with fluid balance. Consistent self-monitoring can alert the patient and healthcare providers to the need for adjustments in treatment.

 

References

• Garofeanu, C. G., Weir, M., Rosas-Arellano, M. P., Hayslett, J. P., & Schrier, R. W. (2005). Causes of reversible nephrogenic diabetes insipidus: a systematic review. American Journal of Kidney Diseases, 45(4), 626-637. This review highlights the importance of proper management of DI, including adherence to prescribed treatments.
• Robertson, G. L. (2016). Diabetes insipidus: Differential diagnosis and management. Best Practice & Research Clinical Endocrinology & Metabolism, 30(2), 205-218. This article discusses the management strategies for DI, emphasizing the critical role of medication adherence and the dangers of unsupervised medication adjustments.

EXPLANATION

 

✔Correct answer:

Diabetes insipidus. In the context of a patient who has just undergone a craniotomy, the sudden onset of an unusually high urine output (polyuria) is highly suggestive of diabetes insipidus (DI), particularly central diabetes insipidus. This condition can emerge as a complication following brain surgery due to potential damage to the hypothalamus or pituitary gland, which are critical in the production, storage, and release of vasopressin (antidiuretic hormone, ADH). Vasopressin regulates the body's retention of water, and its deficiency leads to decreased reabsorption of water in the kidneys, resulting in the production of a large volume of dilute urine. Nurse Daniels' observation of a urine output exceeding 1500 ml per hour for consecutive hours significantly aligns with the symptoms of DI.

Imagine the body's water regulation system as a sophisticated water park, where vasopressin acts as the park's manager, ensuring that the right amount of water flows through the water slides (the kidneys). After a craniotomy, if the park manager (vasopressin) is suddenly absent due to injury (damage from surgery), the water slides start operating without control, letting too much water flow through (producing a large volume of dilute urine). This scenario mirrors the excessive urine output seen in diabetes insipidus.

Central diabetes insipidus results from a lack of vasopressin production or release, which disrupts the normal kidney function of water reabsorption. Normally, vasopressin binds to receptors in the kidneys, promoting the reabsorption of water back into the bloodstream and concentrating the urine. Without adequate vasopressin, this process doesn't occur effectively, leading to the excretion of large amounts of very dilute urine, a hallmark of DI.

 

✘Incorrect answer options:

Cushing’s syndrome. This condition is characterized by excessive cortisol production. Its symptoms include weight gain, thinning skin, and high blood pressure, not specifically polyuria as a primary symptom.

Adrenal crisis. An adrenal crisis is a life-threatening situation resulting from insufficient levels of cortisol. Symptoms include severe weakness, vomiting, and low blood pressure, rather than high urine output.

Diabetes mellitus. While diabetes mellitus can also cause polyuria, in the context of a recent craniotomy, central DI is more likely the cause due to potential damage to the hypothalamus or pituitary gland. Additionally, diabetes mellitus polyuria is associated with hyperglycemia, which would not directly relate to a craniotomy.

 

References

• Smeltzer, S. C., & Bare, B. G. (2020). Brunner & Suddarth's Textbook of Medical-Surgical Nursing. Wolters Kluwer. This textbook provides a comprehensive overview of the management and implications of diabetes insipidus, especially in post-operative care.
• Lewis, S. L., Bucher, L., Heitkemper, M. M., & Harding, M. M. (2017). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier. This resource offers insights into the pathophysiology and nursing considerations for patients with diabetes insipidus following neurological surgeries.

EXPLANATION

 

✔Correct answer:

Checking the vital signs. In a clinical setting, especially when a patient presents with symptoms like polyuria (excessive urination), polydipsia (excessive thirst), and mental confusion, the priority is to assess the patient's immediate physiological stability. Checking the vital signs is crucial as it provides essential information about the patient's current hemodynamic status, including blood pressure, heart rate, respiratory rate, and temperature. These parameters can quickly indicate if the patient is in a state of shock, dehydration, or other acute distress that requires immediate intervention. For a patient with a history of diabetes insipidus, excessive urination can lead to significant fluid and electrolyte loss, which may result in hypotension (low blood pressure), tachycardia (fast heart rate), and changes in mental status due to dehydration or electrolyte imbalances. Therefore, assessing vital signs is a critical first step in determining the severity of the patient's condition and guiding further interventions.

Imagine if you were managing a large event and suddenly noticed several problems arising simultaneously. The first step would be to quickly assess the situation to determine what issue poses the most immediate risk to the safety and well-being of the attendees. Checking vital signs in a patient presenting with symptoms of diabetes insipidus and mental confusion is akin to this quick assessment — it helps healthcare providers identify the most pressing issues that could threaten the patient's life, so they can act swiftly to mitigate these risks.

The symptoms of polyuria and polydipsia in diabetes insipidus result from the body's inability to conserve water due to a lack of effective action of antidiuretic hormone (ADH) or the kidneys' response to it. This leads to significant water loss, which can rapidly progress to dehydration and electrolyte imbalances, affecting vital organs and systems. Mental confusion may arise from severe dehydration or electrolyte disturbances, particularly hyponatremia (low sodium levels), which can alter brain function. Vital signs provide a snapshot of the body's current state of homeostasis and can indicate the severity of these disruptions.

 

✘Incorrect answer options:

Weighing the client is important for monitoring overall fluid balance but is not the immediate priority in a potentially unstable patient.

Measuring the urinary output is crucial for diagnosing and managing diabetes insipidus but comes after stabilizing the patient and assessing vital signs in an acute presentation.

Encouraging the client to increase fluid intake is part of the management plan for diabetes insipidus to compensate for fluid loss. However, it is not the first intervention to perform, especially in a patient with mental confusion, until their hemodynamic status is evaluated and stabilized.

 

References

• Brunner & Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition, by Hinkle, J. L., & Cheever, K. H. This resource emphasizes the importance of initial assessments and prioritizing care based on the acuity of symptoms and vital signs.
• Lewis, S. M., Heitkemper, M. M., Dirksen, S. R., O'Brien, P. G., & Bucher, L. (2020). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier Health Sciences. This textbook outlines the critical steps in evaluating and managing patients with endocrine disorders, highlighting the significance of vital signs in acute presentations.

EXPLANATION

 

✔Correct answer:

Greater than 125% of pre-injection osmolarity. The water deprivation test followed by desmopressin administration is a critical diagnostic tool for differentiating between types of diabetes insipidus and confirming a diagnosis of central diabetes insipidus. In central diabetes insipidus, the body produces insufficient amounts of antidiuretic hormone (ADH), which leads to the production of large volumes of dilute urine. When desmopressin, a synthetic form of ADH, is administered, it compensates for the lack of natural ADH.

For a diagnosis of central diabetes insipidus, after the administration of desmopressin, you would expect a significant increase in urine osmolarity, reflecting the kidney's response to the synthetic ADH by concentrating the urine. An increase in urine osmolarity to greater than 125% of the pre-injection osmolarity indicates a positive response, confirming the diagnosis of central diabetes insipidus. This response shows that the kidneys are capable of concentrating urine in the presence of ADH, pointing to a deficiency in ADH production or release as the underlying problem.

Imagine a sponge that is partially wet (pre-injection urine osmolarity) and has the potential to absorb more water. If you have a spray bottle filled with water (representing desmopressin) and you spray the sponge, the sponge should absorb the water, becoming significantly wetter (post-injection urine osmolarity). If the sponge does indeed become much wetter, it shows that the sponge had the capacity to absorb more water but just wasn't getting enough of it on its own. Similarly, if the kidneys can concentrate urine significantly after receiving desmopressin, it means they have the capacity to do so but aren't receiving the necessary signal (ADH) under normal conditions.

 

✘Incorrect answer options:

Less than 75% of pre-injection osmolarity. This would indicate either no change or a decrease in urine concentration after desmopressin, which would not support a diagnosis of central diabetes insipidus.

Equal to 100% of pre-injection osmolarity. This indicates no change in urine concentration after desmopressin, suggesting that the kidneys are not responding to ADH, which could indicate nephrogenic diabetes insipidus rather than central diabetes insipidus.

Greater than 150% of pre-injection osmolarity. While a significant increase is expected, specifying that the increase must be greater than 150% may not be necessary for diagnosis. The key is a substantial increase indicating responsiveness to ADH, typically quantified as greater than 125%.

 

References

• Diabetes Insipidus Foundation. (n.d.). Diagnosis and Treatment of Diabetes Insipidus. This provides patient-friendly information on how diabetes insipidus is diagnosed, including the role of the water deprivation test and desmopressin administration.
• Clinical Practice Guidelines for the Management of Diabetes Insipidus. These guidelines detail the diagnostic process for diabetes insipidus, including the expected response to desmopressin, aiding healthcare professionals in diagnosis and management.

EXPLANATION

 

✔Correct answer:

Excessive urination (polyuria) and excessive thirst (polydipsia). Diabetes insipidus (DI) is a condition characterized by an imbalance of fluids in the body, leading to excessive urination (polyuria) and excessive thirst (polydipsia). This imbalance is due to the kidneys' inability to properly conserve water, which affects the concentration and volume of urine. DI occurs when the body cannot properly regulate fluid levels, typically due to a lack of the hormone vasopressin (antidiuretic hormone, ADH) or because the kidneys are not responding to ADH. Vasopressin's main role is to signal the kidneys to absorb water back into the body, thus concentrating the urine. In DI, without enough ADH or if the kidneys are resistant to it, too much water is excreted, leading to frequent urination and, as a result, an increased need for fluid intake to prevent dehydration.

Imagine your body as a water tank with a faucet at the bottom. Vasopressin acts like a valve controlling the faucet—when it's working properly, it adjusts the flow to ensure the tank stays adequately full. In diabetes insipidus, it's as if the valve isn't working correctly (either because it's not there or the faucet is ignoring it), so the water keeps flowing out too fast, no matter how much is poured in at the top. This results in the tank (your body) needing constant refilling (drinking water) to try to stay full, but the water keeps leaking out (excessive urination).

Normal fluid balance in the body is maintained through a series of hormonal regulations, primarily involving ADH. ADH is produced in the hypothalamus and stored and released by the pituitary gland. It works on the kidneys to promote reabsorption of water back into the bloodstream, thereby reducing urine volume. In DI, this finely tuned system is disrupted, leading to large volumes of dilute urine and compensatory thirst mechanisms kicking in to avoid dehydration.

 

✘Incorrect answer options:

Weight gain and a general feeling of discomfort or unease (malaise). These symptoms are more nonspecific and are not characteristic of diabetes insipidus. These symptoms could be related to a wide range of conditions, but they do not directly relate to the water regulation problems of DI.

High blood sugar levels (hyperglycemia) and excessive urination (polyuria). These are typically associated with diabetes mellitus, not diabetes insipidus. While polyuria is common to both conditions, the underlying causes and additional symptoms (such as hyperglycemia in diabetes mellitus) differ significantly.

Reduced urine output (oliguria) and low blood sugar levels (hypoglycemia). These are not characteristic of diabetes insipidus. In fact, oliguria would be opposite to the expected symptom of polyuria in DI. Hypoglycemia is also more commonly associated with diabetes mellitus and its management, rather than DI.

 

References

• Lewis, S. M., Dirksen, S. R., Heitkemper, M. M., Bucher, L., & Camera, I. M. (2020). Medical-Surgical Nursing: Assessment and Management of Clinical Problems (11th ed.). Elsevier. This textbook provides comprehensive information on the pathophysiology and management of various conditions, including diabetes insipidus.
• Ignatavicius, D. D., Workman, M. L., & Rebar, C. R. (2018). Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care (9th ed.). Saunders. This book offers detailed insights into endocrine disorders, including diabetes insipidus, focusing on the clinical presentations and treatment approaches.

EXPLANATION

 

✔Correct answer:

Lithium and demeclocycline. Nephrogenic diabetes insipidus (NDI) occurs when the renal tubules do not respond to antidiuretic hormone (ADH), leading to the inability of the kidneys to concentrate urine, resulting in the excretion of large volumes of dilute urine. This condition can be induced by certain medications that interfere with the kidney's response to ADH.

Lithium and demeclocycline are well-known to potentially cause nephrogenic diabetes insipidus. Lithium, used in the treatment of bipolar disorder, can affect the kidney's ability to concentrate urine by interfering with the action of ADH on the renal tubules. Demeclocycline, a tetracycline antibiotic, can similarly antagonize the effects of ADH, leading to a decreased ability of the kidneys to concentrate urine.

Imagine the kidney's ability to concentrate urine as a garden hose with an adjustable nozzle at the end, where the nozzle controls how much water is let out. ADH acts like the mechanism that tightens the nozzle, reducing the flow of water to ensure that only a small, concentrated amount is released, which conserves water in the body.

When medications like lithium and demeclocycline are introduced, it's as if they're interfering with the nozzle's adjustment mechanism, preventing it from tightening properly. As a result, the hose continues to let out water more freely than it should, leading to an increased production of dilute urine, akin to the excessive water loss seen in nephrogenic diabetes insipidus.

ADH plays a critical role in water balance by promoting water reabsorption in the kidneys' collecting ducts, thus concentrating the urine. It does this by binding to V2 receptors on the renal tubules, which in turn stimulates the insertion of aquaporin-2 channels into the tubule cells, allowing water to be reabsorbed back into the bloodstream. Lithium interferes with the signaling pathway downstream of the V2 receptor, preventing the normal action of ADH. Demeclocycline is thought to impair the renal tubule's response to ADH by a similar mechanism, though its exact action is less well understood.

 

✘Incorrect answer options:

Bromocriptine and cabergoline. These drugs are dopamine agonists used primarily in the treatment of Parkinson’s disease and prolactinomas. They do not typically affect the renal response to ADH in a way that leads to nephrogenic diabetes insipidus.

Cimetidine and verapamil. Cimetidine is a histamine H2 receptor antagonist used to treat peptic ulcers, and verapamil is a calcium channel blocker used in the management of hypertension and cardiac arrhythmias. Neither is commonly associated with causing nephrogenic diabetes insipidus.

Hydrochlorothiazide and furosemide. These are diuretic medications used to treat fluid overload conditions and hypertension. While they increase urine production, they do not typically induce nephrogenic diabetes insipidus by antagonizing the effects of ADH on the renal tubules. In fact, hydrochlorothiazide can be used as part of the treatment for nephrogenic diabetes insipidus by inducing a mild volume depletion, which increases proximal sodium and water reabsorption, thus reducing polyuria.

 

References

• Rose, B. D., & Post, T. W. (2019). Clinical Physiology of Acid-Base and Electrolyte Disorders. McGraw-Hill Education. This book provides insights into the mechanisms of action of various drugs on renal function, including those that can cause nephrogenic diabetes insipidus.
• Schrier, R. W. (2017). Diseases of the Kidney and Urinary Tract. Wolters Kluwer Health. This comprehensive resource covers the pathophysiology and management of renal diseases, including drug-induced nephrogenic diabetes insipidus.

EXPLANATION

 

✔Correct answer:

Hyperparathyroidism. The symptoms described by the patient, including increased need for sleep, more frequent urination, loss of appetite, general weakness, irritability, depression, and particularly bone pain, are indicative of hyperparathyroidism. This condition is characterized by the overproduction of parathyroid hormone (PTH) by the parathyroid glands, which leads to elevated levels of calcium in the blood (hypercalcemia). The symptoms reported by the patient align with the effects of hypercalcemia, which can impact various systems in the body, leading to the diverse symptoms noted. The bone pain and weakening are particularly suggestive, as PTH acts to increase blood calcium levels by breaking down bone (bone resorption), which can lead to bone pain and osteoporosis.

Imagine your body as a finely tuned orchestra, with the parathyroid glands acting as the conductor for calcium balance. In hyperparathyroidism, it’s as if the conductor starts directing too loudly (overproduction of PTH), causing the music (calcium levels) to become too loud and overwhelming. This disrupts the harmony (body's balance), leading to various signs and symptoms like the weakening of bones (as if the string section's instruments are being overused and start to wear out), and affecting other parts of the orchestra, such as energy levels and mood.

Parathyroid hormone plays a crucial role in regulating calcium and phosphate levels in the blood. In hyperparathyroidism, the excessive secretion of PTH leads to increased calcium reabsorption from the kidney, increased calcium absorption from the intestines (via its effect on vitamin D metabolism), and increased bone resorption. The resulting hypercalcemia can cause the constellation of symptoms reported by the patient, including polyuria (frequent urination due to the kidney's response to high calcium levels), bone pain (due to calcium being leached from the bones), and neuropsychiatric symptoms (such as depression and irritability, which can be attributed to the effects of high calcium on the nervous system).

 

✘Incorrect answer options:

Diabetes insipidus. This condition primarily affects water balance in the body, leading to polyuria and polydipsia (excessive thirst) but does not typically cause bone pain or hypercalcemia.

Hypoparathyroidism. Characterized by low production of PTH, leading to low calcium levels in the blood (hypocalcemia), which can cause symptoms opposite to those described, such as muscle cramps and spasms, not hypercalcemia.

Diabetes mellitus. While diabetes mellitus can cause increased urination and thirst, its primary symptoms revolve around high blood sugar levels and do not typically include bone pain or the range of symptoms described by the patient related to calcium imbalance.

 

References

• Jameson, J. L., & De Groot, L. J. (2020). Endocrinology: Adult and Pediatric. Elsevier. This textbook provides an in-depth look at the endocrine system, including disorders such as hyperparathyroidism, detailing the physiological effects and symptomatology.
• Williams, R. H., & Nussey, S. (2018). Endocrinology: An Integrated Approach. Oxford University Press. This book explains the feedback mechanisms and hormonal regulations in endocrine disorders, offering insights into the symptoms and management of conditions like hyperparathyroidism.

EXPLANATION

 

✔Correct answer:

Diabetes insipidus. Diabetes insipidus (DI) is an endocrine disorder characterized by the body's inability to regulate water balance, leading to excessive production of dilute urine and increased thirst. The condition is caused by a deficiency of the antidiuretic hormone (ADH), also known as vasopressin, or by the kidneys' inability to respond to ADH. The care plan objectives mentioned by Nurse Hamilton, focusing on adequate fluid replacement and vasopressin replacement, align directly with the management of diabetes insipidus. Fluid replacement is crucial to prevent dehydration due to the significant loss of water through urination, while vasopressin replacement therapy (using medications such as desmopressin) addresses the underlying hormone deficiency, helping to reduce urine output and normalize thirst.

Imagine your body as a sophisticated water management system, where ADH (vasopressin) acts like a regulator that ensures the right amount of water is retained. In diabetes insipidus, this system is malfunctioning — it's as if the regulator is either missing or not working properly, leading to too much water being lost. The treatment focuses on two main things: directly replacing the water that's being lost (fluid replacement) and fixing or replacing the faulty regulator (vasopressin replacement). This approach helps to get the water management system back in balance.

In a healthy individual, ADH plays a key role in water conservation by promoting reabsorption of water in the kidney's collecting ducts, which reduces urine volume and increases its concentration. In diabetes insipidus, due to ADH deficiency (central DI) or renal resistance to ADH (nephrogenic DI), this water reabsorption is impaired, causing large volumes of dilute urine to be produced. Management involves addressing the hormone deficiency to restore water balance and prevent dehydration.

 

✘Incorrect answer options:

Diabetic ketoacidosis (DKA) is a serious complication of diabetes mellitus characterized by hyperglycemia, ketosis, and metabolic acidosis. Management includes fluid and electrolyte replacement, insulin therapy, and monitoring for complications, not vasopressin replacement.

Diabetes mellitus is characterized by hyperglycemia due to insulin deficiency (Type 1) or insulin resistance (Type 2). Management focuses on blood glucose control through diet, exercise, oral hypoglycemics, and/or insulin, not on vasopressin replacement.

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) involves the excessive release of ADH, leading to water retention, hyponatremia, and fluid overload. Management often involves fluid restriction and addressing the underlying cause, contrasting with the need for fluid and vasopressin replacement in DI.

 

References

• Brunner & Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition, by Hinkle, J. L., & Cheever, K. H. This textbook provides a comprehensive overview of the pathophysiology and management of endocrine disorders, including diabetes insipidus.
• Lewis, S. M., Heitkemper, M. M., Dirksen, S. R., O'Brien, P. G., & Bucher, L. (2020). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier Health Sciences. This reference discusses the critical care considerations for patients with diabetes insipidus, emphasizing the importance of fluid and vasopressin replacement.

EXPLANATION

 

✔Correct answer:

It imitates vasopressin and enhances the reabsorption of water by the kidneys. Desmopressin (DDAVP) is a synthetic analog of vasopressin, also known as antidiuretic hormone (ADH), which is used in the management of central diabetes insipidus (DI). Central DI is characterized by a deficiency of vasopressin, leading to decreased water reabsorption in the kidneys, and consequently, the production of large volumes of dilute urine. The primary mechanism of action of desmopressin in treating central DI is that it mimics the action of natural vasopressin. By binding to V2 receptors in the renal collecting ducts, desmopressin increases the permeability of the ducts to water, promoting water reabsorption into the bloodstream, which reduces urine output and concentrates the urine, thereby mitigating the symptoms of DI.

Imagine a water park with several water slides, where the water represents the urine and the slides represent the kidneys' collecting ducts. In central diabetes insipidus, it's as if the slides are wide open, allowing water (urine) to flow out rapidly and in large amounts, leading to a lot of water waste (excessive urine production). Administering desmopressin is like adding a control mechanism to those slides, which can adjust how open they are. When desmopressin acts like vasopressin, it's essentially narrowing the slides (increasing water reabsorption), so less water escapes (less urine is produced), making the water park (body's fluid balance) more efficient and preventing water wastage.

Vasopressin is a crucial hormone for water balance in the body. It is produced in the hypothalamus and stored and released by the posterior pituitary gland. Vasopressin acts on the kidneys to conserve water by triggering the insertion of aquaporin-2 water channels into the membranes of kidney tubules, thereby allowing water reabsorption back into the circulation. In central DI, the body either does not produce enough vasopressin or releases it inadequately, leading to excessive water loss. Desmopressin provides a synthetic means to replicate vasopressin's essential water-conserving function, helping to control the symptoms of central DI.

 

✘Incorrect answer options:

It acts like vasopressin and enhances the excretion of salt by the kidneys. This statement is incorrect because desmopressin's primary role is to enhance water reabsorption, not salt excretion.

It blocks the action of vasopressin and increases the excretion of salt by the kidneys. This is incorrect as desmopressin does not block vasopressin; it mimics its action to promote water reabsorption.

It inhibits vasopressin and promotes the reabsorption of water by the kidneys. This option is incorrect because desmopressin does not inhibit vasopressin; rather, it serves a similar function to vasopressin by enhancing water reabsorption.

 

References

• Brunton, L., Chabner, B., & Knollmann, B. (2021). Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13th Edition. McGraw-Hill Education. This reference explains the pharmacodynamics of desmopressin and its application in treating central diabetes insipidus.
• Lewis, S. L., Bucher, L., Heitkemper, M. M., & Harding, M. M. (2017). Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 10th Edition. Elsevier. This nursing textbook provides detailed information on the management of diabetes insipidus and the role of medications like desmopressin in patient care.

EXPLANATION

 

✔Correct answer:

"If you have nasal discharge or blockage, you may be unable to use the desmopressin nasal spray effectively." Desmopressin (DDAVP) is a synthetic analogue of the natural antidiuretic hormone (ADH) used in the treatment of diabetes insipidus (DI). It acts on the kidneys to reduce urine production and increase water reabsorption, thereby mitigating the symptoms of DI such as polyuria (excessive urination) and polydipsia (excessive thirst). Desmopressin can be administered in several forms, including oral tablets, nasal spray, and injectable form. The nasal spray is a common route of administration because it provides a direct and efficient delivery system. However, its effectiveness can be significantly reduced by nasal congestion, discharge, or any other condition that might impede the absorption of the medication through the nasal mucosa. Therefore, patients should be advised that conditions affecting the nasal passages could impact the efficacy of desmopressin administered via nasal spray.

Imagine using a spray nozzle to water a garden, but the hose is partially blocked or the nozzle is clogged. Even if you have enough water and are using the spray correctly, the water won't reach the plants effectively. Similarly, if there's a blockage (like nasal congestion) when using desmopressin nasal spray, the medication can't be absorbed properly, and its effectiveness in managing DI symptoms is reduced.

Desmopressin works by mimicking the action of natural ADH, targeting the kidneys to enhance water reabsorption and decrease urine volume. When administered nasally, it is absorbed through the nasal mucosa directly into the bloodstream, bypassing the digestive system and avoiding potential degradation of the medication that might occur with oral administration. However, nasal congestion or discharge can prevent the medication from being absorbed efficiently, necessitating adjustments in the administration method or the use of alternative forms of the medication.

 

✘Incorrect answer options:

"You don't need a medical identification bracelet since your condition is not considered chronic." This statement is incorrect. Diabetes insipidus is a chronic condition, and wearing a medical identification bracelet is advisable to alert healthcare providers in case of an emergency, as the patient may require specific medical consideration.

"Make sure to administer the desmopressin while the suspension is cold." This instruction is not accurate. Desmopressin does not need to be administered cold; storage and administration instructions should follow the specific guidelines provided with the medication but generally do not require cold temperatures.

"Once you start taking desmopressin, monitoring your fluid intake and output is not necessary." This statement is misleading. It remains important to monitor fluid intake and urine output even when on desmopressin to avoid potential complications such as water intoxication or dehydration. Patients need to balance their fluid intake with the reduced urine output to maintain proper hydration levels.

 

References

• Robertson, G. L. (2016). Diabetes insipidus: Differential diagnosis and management. Best Practice & Research Clinical Endocrinology & Metabolism, 30(2), 205-218. This article discusses the management strategies for diabetes insipidus, including the use of desmopressin.
• Garofeanu, C. G., Weir, M., Rosas-Arellano, M. P., Hayslett, J. P., & Schrier, R. W. (2005). Causes of reversible nephrogenic diabetes insipidus: A systematic review. American Journal of Kidney Diseases, 45(4), 626-637. This review highlights the causes and treatments of diabetes insipidus, including the impact of nasal conditions on the efficacy of desmopressin nasal spray.

EXPLANATION

 

✔Correct answer:

Vasopressin (Pitressin Synthetic). Diabetes insipidus (DI) is characterized by a deficiency of the antidiuretic hormone (ADH) or a reduced response of the kidneys to ADH, leading to excessive production of dilute urine. Vasopressin, also known as antidiuretic hormone, plays a crucial role in regulating the body's retention of water by increasing water reabsorption in the kidneys. Pitressin Synthetic is a synthetic form of vasopressin and is used in the treatment of central diabetes insipidus, which is caused by insufficient production of ADH by the brain. By administering synthetic vasopressin, the medication compensates for the lack of natural ADH, thereby reducing the symptoms of DI, including polyuria (excessive urination) and polydipsia (excessive thirst).

Imagine the body's water management system is like a garden watering system. In a person with diabetes insipidus, it's as if the system is leaking, causing too much water to be lost. Vasopressin (Pitressin Synthetic) acts like a valve controller that helps to regulate the flow of water, ensuring that just the right amount is retained to keep the garden (the body) properly hydrated without excessive loss.

ADH is produced in the hypothalamus and stored in the posterior pituitary gland. It works by acting on the kidneys to promote water reabsorption into the bloodstream, thus concentrating the urine and reducing urine volume. In central diabetes insipidus, the problem lies in the production of ADH. Synthetic vasopressin like Pitressin Synthetic provides a replacement for the missing hormone, effectively reducing the excessive urine output and helping to normalize the body's water balance.

 

✘Incorrect answer options:

Regular insulin is used in the treatment of diabetes mellitus, a condition characterized by high blood sugar levels due to insufficient production or use of insulin. It is not used in the treatment of diabetes insipidus, which involves a problem with water balance rather than glucose metabolism.

10% dextrose is a solution of glucose in water and is used to treat hypoglycemia (low blood sugar levels) or as a source of calories in intravenous nutrition. It is not used in the management of diabetes insipidus.

Furosemide (Lasix) is a diuretic that promotes the excretion of water and electrolytes by the kidneys. It is used to treat conditions such as edema and hypertension but would be counterproductive in the treatment of diabetes insipidus, as it would exacerbate the already excessive urine production.

 

References

• Brunner & Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition, by Hinkle, J. L., & Cheever, K. H. This comprehensive nursing textbook provides detailed information on the pathophysiology and management of endocrine disorders, including diabetes insipidus.
• Lewis, S. M., Heitkemper, M. M., Dirksen, S. R., O'Brien, P. G., & Bucher, L. (2020). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier Health Sciences. This medical-surgical nursing textbook discusses various medications used in the treatment of endocrine disorders, highlighting the use of vasopressin in managing diabetes insipidus.

EXPLANATION

 

✔Correct answer:

His daily fluid intake is below 2,500 ml. A positive response to treatment for diabetes insipidus, especially when treated with medications like Desmopressin (DDAVP), is primarily indicated by a normalization of water balance in the body. This would be reflected by a reduction in both the excessive thirst (polydipsia) and the excessive urine output (polyuria) that are characteristic of this condition. Since diabetes insipidus leads to the production of large volumes of dilute urine and increased thirst, a decrease in the patient's daily fluid intake to below 2,500 ml indicates that the treatment is effectively reducing urine output and, by extension, the patient's need to consume large amounts of fluid to compensate for losses. This level of fluid intake is closer to the normal range for adults and suggests that the body's ability to concentrate urine and maintain water balance is being restored.

Imagine a leaky water bucket (the body) that you're trying to keep filled by continuously pouring water into it (drinking fluids). If the bucket has a large hole (untreated diabetes insipidus), you'll need a lot of water to keep it filled. Treatment for diabetes insipidus is like patching the hole in the bucket, so you don't need to add water as frequently to keep it at a desired level. If you find yourself needing to pour less water to maintain the water level (fluid intake below 2,500 ml), it means the patch (treatment) is working effectively.

Diabetes insipidus is characterized by impaired water reabsorption in the kidneys due to a deficiency of the antidiuretic hormone (ADH) or a lack of response to it. This leads to the excretion of large volumes of very dilute urine. Normalizing urine concentration and volume is a key goal of treatment. By reducing polyuria and consequently polydipsia, treatment with ADH analogs like Desmopressin helps to achieve water balance, reduce the volume of urine produced, and decrease the patient's excessive thirst and fluid intake.

 

✘Incorrect answer options:

His urine output is consistently over 200 ml/hour. This would indicate continued polyuria, a symptom of untreated or inadequately treated diabetes insipidus, rather than an effective response to treatment.

His blood pressure reads 90/50 mm Hg. Low blood pressure can be a sign of dehydration, which could occur if diabetes insipidus is not effectively managed, rather than indicating successful treatment.

His heart rate is recorded at 126 beats/minute. A high heart rate (tachycardia) can be a sign of dehydration or other systemic stressors and does not indicate effective management of diabetes insipidus.

 

References

• Brunner & Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition, by Hinkle, J. L., & Cheever, K. H. This resource provides insights into the management of diabetes insipidus and expected outcomes of treatment.
• Lewis, S. M., Heitkemper, M. M., Dirksen, S. R., O'Brien, P. G., & Bucher, L. (2020). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier Health Sciences. This textbook discusses the pathophysiology of diabetes insipidus and the therapeutic goals of treatment, including normalization of fluid intake and urine output.

EXPLANATION

 

✔Correct answer:

Urine osmolality is low, while serum osmolality is high. Diabetes insipidus (DI) is a condition characterized by the kidneys' inability to conserve water, leading to the production of large amounts of dilute urine, which in turn can cause an increase in thirst and fluid intake. The hallmark lab findings that confirm DI include low urine osmolality and high serum osmolality.

Urine osmolality is a measure of urine concentration. In DI, the kidneys do not properly concentrate urine, resulting in a low urine osmolality, meaning the urine is more dilute. Serum osmolality, on the other hand, measures the concentration of solutes in the blood. As the body loses water through the production of dilute urine, the concentration of solutes in the blood increases, leading to high serum osmolality. This imbalance reflects the body's inability to concentrate urine and conserve water, a key feature of DI.

Imagine you have two glasses of lemonade, one representing the urine and the other representing the serum. In a healthy situation, both glasses contain the same concentration of lemonade. However, in the case of DI, it's as if you keep adding water to the "urine" glass, making it more diluted, while the "serum" glass remains concentrated because you're not adding any water to it. This scenario illustrates the concept of low urine osmolality and high serum osmolality seen in DI.

The underlying physiology of DI involves a disruption in the normal feedback mechanisms that regulate water balance in the body. This can be due to a deficiency in antidiuretic hormone (ADH), known as central DI, or a resistance to ADH at the kidney level, known as nephrogenic DI. ADH normally promotes water reabsorption in the kidneys, concentrating the urine. In DI, the absence or ineffectiveness of ADH prevents this water reabsorption, leading to the production of large volumes of dilute urine and an increase in blood solute concentration.

 

✘Incorrect answer options:

Urine osmolality is high, while serum osmolality is low. This scenario is more indicative of conditions like syndrome of inappropriate antidiuretic hormone (SIADH), where the body retains too much water, concentrating the urine and diluting the serum.

Both urine and serum osmolality levels are low. This could suggest excessive water intake or other conditions affecting fluid balance, but not DI.

Both urine and serum osmolality levels are high. This scenario could indicate dehydration, where both the body fluids and urine are concentrated due to a lack of water intake, but it does not describe DI.

 

References

• Smeltzer, S. C., & Bare, B. G. (2020). Brunner & Suddarth's Textbook of Medical-Surgical Nursing. Wolters Kluwer. This textbook provides comprehensive information on the pathophysiology, diagnosis, and management of diabetes insipidus.
• Lewis, S. L., Bucher, L., Heitkemper, M. M., & Harding, M. M. (2017). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier. This resource offers detailed explanations on the physiological aspects and clinical care considerations for patients with diabetes insipidus.

EXPLANATION

 

✔Correct answer:

Hypercalcemia and hypokalemia. Diabetes insipidus (DI) is a disorder characterized by the kidneys' inability to conserve water, leading to excessive urination and thirst. Electrolyte imbalances can affect the function of many body systems, including the kidneys' ability to concentrate urine. Specifically, hypercalcemia (high levels of calcium in the blood) and hypokalemia (low levels of potassium in the blood) are known to influence DI.

Hypercalcemia can contribute to DI by interfering with the kidney's ability to concentrate urine. High calcium levels can affect the renal tubules' ability to respond to antidiuretic hormone (ADH), thereby reducing the kidney's capacity to reabsorb water and leading to the production of dilute urine characteristic of DI.

Hypokalemia can also contribute to or exacerbate DI by affecting the renal tubules' function. Low potassium levels can alter the cells' electrical gradients, affecting their ability to concentrate urine and respond to ADH. This disruption can further impair water reabsorption in the kidneys, worsening the symptoms of DI.

Imagine a busy factory (the kidney) that requires electricity (potassium) and a controlled temperature (calcium) to operate efficiently. If there's not enough electricity, the machinery (renal tubules) can't work correctly, and if the temperature is too high, it disrupts the normal operation of the factory. Similarly, in the body, if there's too little potassium or too much calcium, the kidneys can't concentrate urine properly, leading to the excessive urine production seen in DI.

The balance of electrolytes, such as calcium and potassium, is crucial for many cellular processes, including those in the kidneys that concentrate urine. ADH works on the renal tubules, promoting water reabsorption into the bloodstream. Hypercalcemia and hypokalemia disrupt this process by affecting the tubules' responsiveness to ADH and altering the electrical and osmotic gradients necessary for water reabsorption, thereby exacerbating the symptoms of DI.

 

✘Incorrect answer options:

Hypocalcemia (low calcium levels) and hypokalemia (low potassium levels). These are not typically associated with causing or exacerbating DI. While hypokalemia does play a role, hypocalcemia generally does not have the same impact on DI as hypercalcemia.

Hypocalcemia and hyperkalemia (high potassium levels). These are also not commonly associated with DI. While electrolyte imbalances can affect the body in various ways, this combination does not specifically contribute to the development or exacerbation of DI.

Hypercalcemia and hyperkalemia (high levels of both calcium and potassium). These do not represent the typical electrolyte disturbances associated with DI. While hypercalcemia is a factor, hyperkalemia, unlike hypokalemia, is not typically implicated in DI.

 

References

• Adrogué, H. J., & Madias, N. E. (2020). Sodium and potassium in the pathogenesis of hypertension. New England Journal of Medicine, 342(21), 1493-1499. This source explains the role of electrolytes in various disease processes, including their impact on kidney function.
• Palmer, B. F., & Clegg, D. J. (2016). Electrolyte and acid-base disturbances in patients with diabetes insipidus. Clinical Journal of the American Society of Nephrology, 11(10), 1824-1832. This article discusses the relationship between electrolyte imbalances and diabetes insipidus, focusing on the pathophysiology and clinical implications.

EXPLANATION

 

✔Correct answer:

Antidiuretic hormone (ADH). Diabetes insipidus (DI) is primarily characterized by a deficiency in Antidiuretic Hormone (ADH), also known as vasopressin. ADH is a hormone produced in the hypothalamus and stored and released by the posterior pituitary gland. Its main function is to regulate the body's retention of water by increasing water reabsorption in the kidneys' collecting ducts. This process concentrates the urine and reduces urine volume. In the absence or insufficient levels of ADH, or if the kidneys do not respond properly to ADH, the body fails to reabsorb water, leading to the production of a large volume of dilute urine, which is the hallmark of DI.

Consider ADH as a manager in charge of water conservation in a water park. The manager's job is to ensure that water is recycled and retained within the park efficiently, allowing for optimal operation without wasting resources. If the manager (ADH) is absent or not doing their job effectively, water (in this case, urine) flows out of the park (body) in large, uncontrolled amounts, leading to a constant need to replenish the water supply (thirst and excessive drinking).

ADH plays a crucial role in fluid homeostasis by acting on the kidneys to promote water reabsorption into the bloodstream, thereby reducing urine output and concentrating the urine. It binds to receptors on the cells in the kidney tubules, triggering a cascade of events that lead to the insertion of water channels (aquaporins) into the cell membranes, allowing water to be reabsorbed by osmosis. In DI, the lack of ADH action (due to a deficiency in ADH or resistance to ADH by the kidneys) prevents this water reabsorption, resulting in large amounts of very dilute urine and compensatory polydipsia (excessive thirst).

 

✘Incorrect answer options:

Follicle-stimulating hormone (FSH) is involved in the regulation of reproductive processes, including the development of eggs in women and sperm production in men, and has no direct role in water balance or the symptoms associated with DI.

Luteinizing hormone (LH) also plays a key role in the reproductive system, triggering ovulation in women and stimulating testosterone production in men, and is not related to the regulation of urine production or concentration.

Thyroid-stimulating hormone (TSH) regulates the production of thyroid hormones, which influence the body's metabolic rate, growth, and development, but it does not directly affect water reabsorption in the kidneys or contribute to the development of DI.

 

References

• Baylis, P. H. (2020). The physiology of vasopressin release and its control. In V. R. Preedy (Ed.), Vasopressin and Oxytocin: From Genes to Clinical Applications (pp. 23-39). Elsevier. This source provides an in-depth look at the role of ADH in the body and its mechanisms of action.
• Robertson, G. L. (2016). Diabetes insipidus: Differential diagnosis and management. Best Practice & Research Clinical Endocrinology & Metabolism, 30(2), 205-218. This article discusses the diagnosis and management of DI, emphasizing the central role of ADH deficiency or insensitivity.

EXPLANATION

 

✔Correct answer:

Hourly measurement of urine output. Diabetes insipidus (DI) is a condition characterized by the kidneys' inability to conserve water, leading to the production of large amounts of dilute urine. This condition is not related to blood glucose levels or the functioning of the pancreas, as seen in diabetes mellitus. Instead, DI is related to the antidiuretic hormone (ADH), either due to insufficient production by the brain (central DI) or the kidneys' failure to respond to ADH (nephrogenic DI). Hourly measurement of urine output is the most direct and effective method for assessing diabetes insipidus because it provides immediate information about the volume and frequency of urination, which are key indicators of the condition. Patients with DI typically excrete large volumes of urine – up to 20 liters per day, compared to the normal range of 1-2 liters – even when they are not consuming excessive amounts of fluids. This symptom is a direct result of the body's inability to concentrate urine due to a lack of ADH activity or response.

Imagine you have a water tank with a hose attached to it. Normally, a valve controls how much water is released through the hose, depending on the need. In the case of diabetes insipidus, it's like the valve is stuck open, so water continuously flows out of the tank no matter how much water is needed for the garden, leading to a constant and excessive outflow. Regularly checking how much water is lost from the tank (similar to measuring urine output) tells you exactly how severe the problem is with the valve (in this analogy, the valve represents the body's ability to concentrate urine).

In a healthy individual, ADH regulates the reabsorption of water in the kidneys. When body water levels are low, ADH levels increase, leading to greater water reabsorption in the kidneys and the production of more concentrated urine. In DI, this mechanism is disrupted due to either a lack of ADH production or the kidneys' inability to respond to ADH, leading to excessive loss of water in the urine and subsequent symptoms like increased thirst and large volumes of dilute urine.

 

✘Incorrect answer options:

Regular monitoring of blood glucose levels. This method is crucial for the diagnosis and management of diabetes mellitus but not diabetes insipidus, as DI does not involve blood glucose levels.

Evaluating arterial blood gas (ABG) values every other day. ABG measurements are essential for assessing acid-base balance and gas exchange in conditions affecting the respiratory or metabolic systems but are not directly relevant to the diagnosis of diabetes insipidus.

Recording vital signs every 4 hours. While monitoring vital signs is a fundamental aspect of assessing a patient's overall health, it does not specifically address the excessive urine production and inability to concentrate urine that characterize diabetes insipidus.

 

References

• Lewis, S. M., Heitkemper, M. M., Dirksen, S. R., O'Brien, P. G., & Bucher, L. (2020). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier Health Sciences. This textbook provides comprehensive information on the pathophysiology and management of diabetes insipidus.
• Brunner & Suddarth's Textbook of Medical-Surgical Nursing (14th Edition) by Hinkle, J. L., & Cheever, K. H. (2018). This reference offers detailed explanations of the mechanisms of diseases like diabetes insipidus and the rationale behind diagnostic and treatment strategies.

EXPLANATION

 

✔Correct answer:

Hypothalamus. Central diabetes insipidus is primarily due to a problem with the hypothalamus. This condition arises when there's a deficiency in the production, storage, or release of antidiuretic hormone (ADH), also known as vasopressin. The hypothalamus produces ADH, which is then stored in the posterior pituitary gland until needed. ADH plays a crucial role in regulating water balance in the body by signaling the kidneys to reabsorb water, thereby concentrating the urine and reducing urine output.

Damage to the hypothalamus can disrupt the production of ADH, leading to central diabetes insipidus. This can result from various causes, including trauma, infection, surgery, or tumors, affecting the hypothalamus or the pituitary stalk, thereby impeding ADH's transport to the pituitary gland for storage and release.

Imagine the body's water conservation mechanism as a smart irrigation system in a garden, where the hypothalamus is the control center that decides when and how much water should be conserved based on the garden's needs. ADH is like the command sent from the control center to the valves in the irrigation system (the kidneys), telling them to hold back water when necessary to prevent waste. If the control center is damaged, it can't send out the correct commands, leading to a situation where the valves stay open, and too much water is lost, akin to the excessive urine production seen in central diabetes insipidus.

 

✘Incorrect answer options:

Pituitary gland. While the pituitary gland is involved in the storage and release of ADH, the primary issue in central diabetes insipidus lies with the hypothalamus's ability to produce ADH. However, damage to the pituitary gland can also lead to central diabetes insipidus by affecting the storage and release of ADH.

Parathyroid gland. The parathyroid glands regulate calcium levels in the body and are not directly involved in the production or action of ADH.

Kidneys. The kidneys are the organ affected by the lack of ADH in diabetes insipidus, leading to excessive urination. However, they are not the cause of central diabetes insipidus, which originates from a deficiency in ADH production by the hypothalamus.

 

References

• Williams Textbook of Endocrinology. This authoritative source provides comprehensive information on the endocrine system, including the regulation of water balance by ADH and the pathophysiology of diabetes insipidus.
• Clinical Guidelines for Management of Diabetes Insipidus. These guidelines offer practical insights into diagnosing and managing diabetes insipidus, emphasizing the role of the hypothalamus and pituitary gland.

EXPLANATION

 

✔Correct answer:

Fluid intake and urine output. Desmopressin acetate (DDAVP) is a synthetic analogue of the naturally occurring antidiuretic hormone (ADH), which plays a crucial role in regulating water balance in the body. It is used in the treatment of central diabetes insipidus, a condition characterized by the insufficient secretion of ADH from the pituitary gland, leading to excessive urine production and thirst. DDAVP works by increasing water reabsorption in the kidneys, thereby reducing urine volume and concentrating the urine. The effectiveness of DDAVP in managing diabetes insipidus is best evaluated by monitoring changes in the patient's fluid intake and urine output. A successful response to the treatment would be indicated by a decrease in urine output and an improvement in the patient's ability to concentrate urine, along with a reduction in excessive thirst and a normalization of fluid intake levels.

Think of the body as a factory that processes liquids. In a person with diabetes insipidus, it's as if this factory is working overtime, producing too much waste water (urine) because it can't properly recycle the water back into the system. Desmopressin acts like a manager who steps in to adjust the machinery (kidneys), making it more efficient at recycling water, thus reducing the amount of waste water produced. Monitoring the input (fluid intake) and output (urine) of the factory gives us a clear idea of how well the manager's adjustments are working.

ADH's primary function in the body is to regulate water balance by promoting the reabsorption of water in the kidney's collecting ducts, which conserves water and produces concentrated urine. In diabetes insipidus, due to a deficiency in ADH (central DI) or resistance to its effects (nephrogenic DI), this water reabsorption does not occur effectively, leading to the production of large volumes of dilute urine. Desmopressin acts on the kidneys to mimic the effect of ADH, thereby reducing urine volume and increasing its concentration.

 

✘Incorrect answer options:

Serum glucose levels. While monitoring serum glucose levels is essential in diabetes mellitus, it is not relevant for evaluating the effectiveness of DDAVP in treating diabetes insipidus, as this condition does not directly affect blood glucose levels.

Arterial blood pH. Arterial blood pH is a measure of acid-base balance in the body and is not directly related to the action of DDAVP or the primary symptoms of diabetes insipidus. Therefore, it would not be a relevant parameter to monitor in assessing the effectiveness of DDAVP treatment.

Pulse rate. Although the pulse rate is an important vital sign, it does not provide specific information about the effectiveness of DDAVP in managing diabetes insipidus. Changes in pulse rate could be influenced by a variety of factors and would not directly reflect changes in urine concentration or volume.

 

References

• Brunner & Suddarth's Textbook of Medical-Surgical Nursing, 14th Edition, by Hinkle, J. L., & Cheever, K. H. This book provides detailed information on the management of diabetes insipidus, including the use of desmopressin.
• Lewis, S. M., Heitkemper, M. M., Dirksen, S. R., O'Brien, P. G., & Bucher, L. (2020). Medical-Surgical Nursing: Assessment and Management of Clinical Problems. Elsevier Health Sciences. This textbook discusses the pharmacological treatments for conditions like diabetes insipidus and the importance of monitoring fluid balance.